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Intensity modulated radiotherapyBackground and purpose: To recommend contouring methods and atlas of organs at risk (OARs) for
nasopharyngeal carcinoma (NPC) patients receiving intensity-modulated radiotherapy, in order to help
reach a consensus on interpretations of OARs delineation.
Methods and materials: Two to four contouringmethods for themiddle ear, inner ear, temporal lobe, parotid
gland and spinal cord were identiﬁed via systematic literature review; their volumes and dosimetric
parameters were compared in 41 patients. Areas under the receiver operating characteristic curves for
temporal lobe contouring were compared in 21 patients with unilateral temporal lobe necrosis (TLN).
Results: Various contouring methods for the temporal lobe, middle ear, inner ear, parotid gland and spinal
cord lead to different volumes and dosimetric parameters (P < 0.05). For TLN, D1 of PRV was the most
relevant dosimetric parameter and 64 Gy was the critical point. We suggest contouring for the temporal
lobe, middle ear, inner ear, parotid gland and spinal cord. A CT–MRI fusion atlas comprising 33 OARs was
developed.
Conclusions: Different dosimetric parameters may hinder the dosimetric research. The present
recommendation and atlas, may help reach a consensus on subjective interpretation of OARs delineation
to reduce inter-institutional differences in NPC patients.
 2014 The Authors. Published by Elsevier Ireland Ltd. Radiotherapy and Oncology 110 (2014) 390–397
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-
sa/3.0/).Radiotherapy is the preferred therapeutic modality for
non-metastatic nasopharyngeal carcinoma (NPC). Intensity
modulated radiotherapy (IMRT) is currently the mainstay of
radiation oncology. Accurate delineation and precise dosage of the
target volume and organs at risk (OARs) are the keys to successful
radiotherapy.
Many normal tissues close to the nasopharynx are deﬁned as
OARs, including the temporal lobe, brainstem, spinal cord, optic
nerve, chiasm, parotid gland, submandibular gland, pituitary
et al.; therefore, treatment planning is difﬁcult in NPC. Furthermore,critical normal tissues such as the brainstem and temporal lobe are
so close to the target volume that inaccurate delineation will
mislead treatment planning, resulting in inadequate target volume
coverage or OAR overdose. Thus, accurate and consistent OARs
delineation in NPC is critical. However, large variations were
observed when contouring OARs [1–3]. Furthermore, signiﬁcantly
different contouring methods are also recommended in the
literature. For example, when contouring the inner ear, some
clinicians delineate the cochlea alone, the internal auditory canal
(IAC) in combination with the vestibule and cochlea, the IAC and
cochlea, or the vestibule and cochlea [4–7]. Such diversity in OAR
contouring will certainly generate unmatched dosimetric
parameters, and prevents side effect correlation studies. Thus,
guidelines for OARs delineation are necessary. The considerable
variation in OARs delineation mainly originates from the diversity
of subjective interpretations and variation in actual contouring. In
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interpretations.
We identiﬁed different OARs contouring methods and applied
these methods in 41 NPC patients, to compare the volumes and
dosimetric parameters. Furthermore, as an example, we retrospec-
tively compared the areas under the receiver operating character-
istic (ROC) curves for two temporal lobe contouring methods in 21
NPC patients with unilateral temporal lobe necrosis (TLN) who
underwent IMRT. A more reasonable contouring method for tem-
poral lobe was obtained. Finally, we recommend a contouring
method and atlas of the OARs in NPC patients, for which we expect
to reach a consensus on interpretations of OARs delineation.Methods and materials
Delineation methods
A review of the literature regarding OARs delineation in head
and neck cancer (HNC) revealed two to four contouring methods
for the middle ear, inner ear, temporal lobe, parotid gland and
spinal cord. Information for this review was identiﬁed by searches
of PubMed using the name of the organs (such as temporal lobe,
et al.) and search terms ‘‘contouring’’, ‘‘delineation’’ or speciﬁc
radiation injuries (such as temporal lobe necrosis, temporal lobe
injury, et al.) and ‘‘radiation therapy’’/‘‘radiotherapy’’ in the title/
abstract (or radiation injury and ‘‘radiation therapy’’/‘‘radiother-
apy’’ in title for the spinal cord and parotid gland). References were
supplemented with relevant citations from the reference lists of
the retrieved papers. Relevant papers were deﬁned as clinical stud-
ies or reviews elaborating on the organs contouring or presenting
pictures of delineated OARs on sectional CT or MRI. Papers pub-
lished until the end of November 2012 were included. All papers
identiﬁed in the searches were selected on the basis of the above
criteria by the ﬁrst author (Sun Y.) after reading the abstract. To-
tally, 97, 146, 178, 94 and 38 papers were identiﬁed and 5, 30,
13, 7 and 7 papers were found to be relevant for the temporal lobe,
parotid gland, spinal cord, inner ear and middle ear, respectively
(Supplementary References 1). For the other OARs, different con-
touring methods were few referred [8–10].
Two methods were used to contour the temporal lobe. The ﬁrst
included brain tissue outside the Sylvian ﬁssure and basal ganglia,
excluding the parahippocampal gyrus and hippocampus (method
1); the other method contoured the temporal lobe including the
parahippocampal gyrus and hippocampus, excluding the basal
ganglia and insula (method 2) [11]. Three middle ear contouring
methods were identiﬁed: contouring the combination of tympa-
num and Eustachian tube (ET) [5]; the tympanum and bony part
of the ET respectively, [12]; or the ET, tympanic cavity and mastoid
process, respectively [13]. As described above, four methods were
observed for inner ear [4–7]. Spinal cord contouring included the
true spinal cord [14], or the bony limits of the spinal canal [15].
Chau et al. split the parotid gland into the gross tumor volume-
overlapping, planning target volume-overlapping and non-target-
overlapping sub-segments [16]. As no parotid gland involvement
was detected in this study, we delineated the complete parotid
gland and non-target-overlapping sub-segments. By reviewing at-
lases of anatomy [8–10], we deﬁned 3D-boundaries for other OARs,
and suggested representative contouring according to their ana-
tomic locations on CT–MRI fusion.Application of different contouring methods
A total of 41 consecutive, newly diagnosed, non-metastatic NPC
patients were treated in our hospital between March 2011 and
September 2011. The patients’ characteristics are presented in Sup-
plementary Table 1.According to International Commission on Radiation Units and
Measurements (ICRU) reports 50, 62 and 83, we contoured the
gross target volume (GTV), clinical target volume (CTV) and OARs
using the delineation methods described above. Atlas-based auto
segmentation (ABAS, Version 2.01, ELEKTA CMS, INC., Stockholm,
Sweden) was used to generate primary OARs delineation. Then,
the contouring was modiﬁed and completed by Sun Y. who special-
izes in HNC with 11 years work experience, and then was reviewed
by a radiologist (Zhang R.) with more than 20 years work experi-
ence. The differences were resolved by group discussion. A 3 mm
margin was used to generate the corresponding planning target
volume and planning organs at risk volume (PTV/PRV). A total dose
of 70 Gy at 2.12 Gy per fraction (5 fractions per week) was pre-
scribed. According to the Radiation Therapy Oncology Group
(RTOG) protocols 0225 and 0615 and ICRU report 83, we calculated
the volume of all organs; the mean dose (Dmean) for the parotid
gland, middle and inner ear, D1 of PRV (Dx/xcc, the minimum dose
received by the ‘‘hottest’’ x% or x ml of the structure) for the spinal
cord and temporal lobe to compare the different contouring
methods.Selection of temporal lobe contouring methods
We retrospectively analyzed the dosimetric parameters in 21
NPC patients with unilateral TLN who underwent IMRT between
November 2004 and November 2006. The patients’ characteristics
are presented in Supplementary Table 1.
The median follow-up time was 45 months (range: 38–
63 months) and the latency of TLN was 35 months (range:
25–57 months) after completion of radiotherapy. The patients
underwent follow-up (clinical and/or imaging examinations)
monthly in the ﬁrst three months after completion of radiotherapy,
every three months in the ﬁrst three years, every six months in the
next two years, and annually thereafter. MRI was required every
six months during the ﬁrst 2 years and annually thereafter, and
was also performed when tumor recurrence or TLN was suspected
[17]. MRI ﬁndings were independently reviewed by two radiolo-
gists, and any disagreements were resolved by consensus. A diag-
nosis of TLN will be made if the MRI presented following signs,
(1) WMLs (homogeneous lesions in the white matter); (2) solid,
enhanced nodules with or without a necrotic center and ﬁnger
signs; (3) cysts of round or oval lesions [18–19]. Tumor recurrence
or metastasis of tumor was excluded.Statistical analysis
SPSS 16.0 was used for data analysis. We performed the Fried-
man test to compare middle/inner ear Dmean; the paired-t test
to compare parotid gland volume and Dmean, spinal cord volume
and D1 of PRV; the Wilcoxon-test to compare temporal lobe the
volume, and D1 of PRV for the 41 patients.
For the 21 patients with unilateral TLN, three steps were
adopted. Firstly, the paired-t test was used to compare all the dosi-
metric parameters (the D1–D60, D1–D40 cc, V10 [Vx, the percent-
age volume of the organ which received more than  Gy] to V75,
D1–D60 of PRV, and V20–V75 of the PRV at ﬁve units intervals) be-
tween the temporal lobes with and without radiation-induced
damage for every method. All of the signiﬁcantly different param-
eters from the paired t-tests were separately included in the next
analyses. Secondly, multivariate analysis using the binary logistic
regression model was used to identify the most relevant parame-
ters associated with TLN. Lastly, the areas under the ROC curves
of the most relevant parameters from the two contouring methods
were compared to select a more reasonable contouring method.
P < 0.05 was considered signiﬁcant.
Table 2
Multivariate analysis of the two temporal lobe contouring methods in 21 NPC
patients with TLN.
Ba S.E. Waldb P-value
Method 1c
D1 of PRVd 2.69 1.36 3.91 0.05
D40cce -0.48 0.18 6.82 0.009
D0.5 cce -1.84 1.10 2.780 0.095
Method 2f
D1 of PRVd 0.57 0.18 10.53 0.006
V10g -0.2 0.07 7.61 0.001
Abbreviations: S.E., standard error; PRV, planning organ at risk volume.
a b, meaning the regression coefﬁcient.
b Wald, the nonzero test of the regression coefﬁcients.
c Temporal lobe including the basal ganglia and insula, excluding parahippo-
campal gyrus and hippocampus.
d D1 of PRV is the minimum dose received by the ‘‘hottest’’ 1% of the temporal
lobe PRV.
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Comparison of dosimetric parameters in the OARs using different
contouring methods
Signiﬁcant differences in the volume and selected parameters of
all organs were observed using different contouring methods
(P < 0.05; Table 1).
Signiﬁcant differences between the ipsilateral and contralateral
temporal lobe were observed for all dosimetric parameters
(P < 0.05, Supplementary Table 2). The D1 of PRV was identiﬁed
as the most relevant parameter for TLN for both methods (Table 2).
The method 2 has a slightly larger area under the ROC curve than
method 1 (0.86 vs. 0.85); 64 Gy was the critical point for the D1 of
PRV (Supplementary Fig. 1). There was no signiﬁcant difference
between the areas under the ROC curves of the two contouring
methods (P = 0.27).e D0.5cc is the minimum dose received by the ‘‘hottest’’ 0.5 ml of the temporal lobe
volume; D40cc is the minimum dose received by ‘‘hottest’’ 40 ml of the temporal
lobe volume.
f Temporal lobe including parahippocampal gyrus and hippocampus, excluding
basal ganglia and insula.
g V10 is the volume percentage of the temporal lobe that received more than
10 Gy.Recommendation for OARs contouring
Based on the anatomic deﬁnition and pathogenesis of radiation-
induced injury, we recommend a reasonable contouringmethod for
temporal lobe, middle ear, inner ear, parotid gland and spinal cord
(Table 3). For other organs whose contouring is rarely described, we
recommend outlining the whole organ according to their anatomic
deﬁnition [8–10,22–24] (Supplementary Table 3). The middle ear,
inner ear and TMJ should be delineated on the bone window
(1400–1600/400–600 HU or 3000–4500/600–800 HU) [5,25],
the temporal lobe and brainstem on the brain windows (80–100/
35–50 HU); however, the lateral boundary of the temporal lobe
and other organs should be delineated on the soft tissue window
(300–400/20–120 HU, Fig. 1) [25]. The complete OARs contouring
atlas is presented in Supplementary Fig. 2.Table 1
Comparison of dosimetric parameters for the OARs using different contouring methods in
Organs Volume (ml)
Middle ear
Middle eara 19.4 ± 1.0
Tympanic cavity 0.7 ± 0.2
ET 0.2 ± 0.02
Tympanic cavity + ETb 0.5 ± 0.1
Mastoid process 16.8 ± 0.9
Inner ear
Inner earc 2.9 ± 0.1
Cochlea 0.2 ± 0.004
Vestibule 0.3 ± 0.01
Vestibule + cochlead 0.5 ± 0.1
IAC 0.3 ± 0.2
Parotid gland
Complete parotid 28.9 ± 1.0
Spared parotide 24.1 ± 1.0
Volume (ml)
Spinal cord
True spinal cord 22.4 ± 2.1
Vertebra canalf 36.5 ± 5.2
Temporal Lobe
Method 1g 94.9 ± 1.3
Method 2h 102.7 ± 1.4
Abbreviations: OAR, organ at risk; ET, Eustachian tube; IAC, internal auditory canal; PRV
a Whole middle ear including tympanic cavity, bony part of ET and mastoid process.
b Combination of tympanum and bony part of ET.
c Whole inner ear including the cochlea, vestibule and IAC.
d Combination of vestibule and cochlea.
e Non-target-overlapping sub-segment.
f Outlined according to the bony limits of the spinal canal.
g Temporal lobe excluding parahippocampal gyrus and hippocampus, including the b
h Temporal lobe including parahippocampal gyrus and hippocampus, excluding the b
i Dx, the minimum dose received by the ‘‘hottest’’ x% of the organ; Dmean, mean dosWe suggest the temporal lobe includes the hippocampus,
parahippocampal gyrus and uncus; the basal ganglia and insula
are located anteriorly and superiorly to the hippocampus and
parahippocampal gyrus should be excluded. Gondi et al. further
elaborated on the location of the hippocampus on MRI [26]. We
suggest contouring the tympanic cavity and bony part of the ET
individually. The tympanic cavity is delineated laterally by the
tympanic membrane, deﬁned by the ligature between the twoNPC patients receiving IMRT.
P-value Dmean (Gy)i P-value
<0.001 35.4 ± 0.6 <0.001
49.1 ± 0.9
60.0 ± 0.8
51.5 ± 0.9
34.6 ± 0.6
<0.001 46.0 ± 0.8 <0.001
52.1 ± 0.9
41.7 ± 0.9
45.9 ± 0.8
49.4 ± 0.9
<0.001 40.5 ± 5.9 <0.001
34.4 ± 5.8
P-value D1 of PRV (Gy)i P-value
<0.001 44.7 ± 0.9 0.001
48.1 ± 1.6
<0.001 64.0 ± 0.7 0.003
63.4 ± 0.6
, planning organ at risk volume.
asal ganglia and insula.
asal ganglia and insula.
e received by organ.
Table 3
Anatomic boundaries of the temporal lobe, parotid gland, spinal cord, middle ear and inner ear in NPC.
Organ Standard TPS
name [20]
Cranial Caudal Anterior Posterior Lateral Medial
Temporal
lobe
TemporalLobea Cranial edge of
the sylvian
ﬁssure
Base of middle
cranial fossa
Temporal bone
and sylvian
ﬁssure, greater
wing of
sphenoid
Petrous part of temporal
lobe, tentorium of
cerebellum, incisura
preoccipitalis
Temporal bone Cavernous sinus, sphenoid
sinus, sella turcica, and
sylvian ﬁssure including
parahippocampal gyrus and
hippocampus
Parotid
gland
[21]
Parotida External
auditory canal,
mastoid
process
Appearance
post. part
submandibular
space
Masseter m.
post. border
mandibular
bone, medial
pterygoid m.
Ant. belly
sternocleidomastoid m.,
lat. side post. belly of the
digastric m. (posterior
medial), mastoid process
Submandibular
fat, platysma
Post. belly of the digastric m.,
styloid process,
parapharyngeal space,
sternocleidomastoid
Spinal
cord
SpinalCord Disappearance
of cerebellum
Two
centimeters
below the
inferior edge of
the clavicular
head
Exclude the subarachnoid space
Inner ear Ear_Innera Cochlea and internal auditory canal should be individually delineated and named
Middle
ear
Ear_Middlea Tympanic cavity, bony part of Eustachian tube should be individually delineated and named
a The organs should be divided into left and right, and the standard TPS name of laterality is indicated by appending an underscore character (_), followed by L or R,
respectively. For example, the left parotid is named Parotid_L; the right parotid is named Parotid_R.
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posterior walls of the most medial aspect of the outer air canal
[5], the sharp narrow region connected interiorly to the ET, and
the interface between the temporal bone and air at all other walls.
For the inner ear, we suggest delineation of the cochlea and IAC
individually. The cochlea is located anteriorly to the IAC [5]. The
visible true spinal cord should be contoured from the foramen
magnum (the level of the odontoid process of the axis) to 2 cm be-
low the inferior edge of the head of the collarbone. The whole par-
otid gland should be outlined, including the external carotid artery
[11] and the region within CTV, but not the GTV. Water et al. elab-
orate further on deﬁnitive bordering of the parotid gland [23].
Discussion
Accurate and consistent OARs delineation is critical for IMRT.
However, considerable heterogeneity contouring has been ob-
served in OARs contouring [1–3]. Nelms et al. found the most var-
iable contour in HNC occurred in the brainstem, parotid glands and
spinal cord, with mean consistency scores less than 70/100 [1].
Such contouring variations originated from both the subjective
diversity of OARs interpretation and variation in actual contouring.
In this study, we mainly focused on subjective OARs interpretation
which varies signiﬁcantly through a literature review. Various con-
touring methods will lead to different dosimetric parameters, and
prevents dosimetry/side effect correlation studies. Thus, a uniform
contouring is necessary to minimize contouring variations.
For the 21 NPC patients with unilateral TLN, paired t-test was
ﬁrst used to exclude the irrelevant parameters with TLN. The mul-
tivariate analysis using the binary logistic regression model was
used to identify the most relevant parameters. Lastly, the most rel-
evant parameters from the two methods were analyzed using the
ROC curve, which has been used in NPC to select a prognostic factor
and the critical point [27–28]. In this study, the value of D1 of PRV
can better reﬂect the development of TLN if one method has a big-
ger area under the ROC curve than the other one. The critical point
was deﬁned by achieving a minimum of 80% sensitivity and within
this constraint maximized the sensitivity and speciﬁcity with the
maximum Youden score [27–29].
In this study, we demonstrated that various contouring meth-
ods will lead to different dosimetric parameters, in contrast to Feng
et al. who reported that treatment planning optimization was notsubstantially affected by different OAR contours [2]. This discrep-
ancy can be explained as follows: Firstly, we evaluated the differ-
ent contouring methods with a large subjective diversity of OARs
interpretation, rather than the reproducibility of the same inter-
pretation. Secondly, Feng et al. evaluated the doses received by
the organs which are relatively far away from the target volume.
However, in our study, the temporal lobe, inner ear, etc. are closer
to the nasopharyngeal target volume, often lie on steep dose gradi-
ents; therefore, the dose of these OARs may be impacted more sig-
niﬁcantly by contouring uncertainties.
Radiation-induced temporal lobe injury is characterized by TLN,
observed in 1–56% of NPC patients after radiotherapy [30,31]. Our
study retrospectively compared the areas under the ROC curves
for two different temporal lobe contouring methods, found the D1
of PRV was the most relevant dosimetric parameter for TLN, and
64 Gywas the critical dose, similar to the 65 Gy limit recommended
by RTOG 0225 protocol. The area under the ROC curves was not sig-
niﬁcantly different between the two contouring methods. This may
be explained as follows: The D1 of PRV is mainly impacted by the
inferior and medial aspect of the temporal lobe [17], where TLN is
mostly observed [32]. Bothmethods included the inferior andmed-
ial aspect. Thus, no signiﬁcant difference was observed in the asso-
ciations of D1 of PRV with the development of TLN.
The biggest controversy in contouring the temporal lobe is
whether the hippocampus, parahippocampal gyrus, basal ganglia
and insula should be included. We recommend method 2 for the
following reasons. Firstly, the hippocampus and parahippocampal
gyrus are located close to the target volume, in which the TLN usu-
ally occurred (13/21 in this study), while in the basal ganglia and
insula rarely occurred (1/21 in this study). Secondly, the symptoms
of TLN such as decreased memory, acalculia et al. are correlated
with the damage to the hippocampus and parahippocampal gyrus.
Finally, method 2 is consistent with the anatomic deﬁnition of the
temporal lobe.
Radiation-induced middle ear damage is characterized by otitis
media with effusion (OME), suffered by 26–40% NPC patients with-
in 5 years after radiotherapy [12,33]. Two factors contributed to
OME: (1) damage to the ET, tensor veli palatini muscle, cartilage
or nerves; (2) direct radiation damage leading to noninfectious
inﬂammation [13]. Therefore, the injuries of ET and tympanic cav-
ity (including the otosteon) are relevant to the development of
OME and should be contoured and protected individually.
394 Suggested contouring of the OARs in NPCInner ear radiation-induced injury is mainly responsible for sen-
sorineural hearing loss (SNHL), with morbidity rates of 11–57%
[4,34]. The precise mechanisms are obscure. Our recommendation
to contour the cochlea and IAC individually is based on the innerFig. 1. Brief atlas oear function. During sound transmission, vibration passes from
the tympanic membrane to the otosteon, fenestra vestibule and
through the cochlea to vibrate the cochlear basilar membrane
and produce nerve impulses, which are transported into thef OARs in NPC.
Fig. 1 (continued)
Y. Sun et al. / Radiotherapy and Oncology 110 (2014) 390–397 395auditory center via the cochlear nerve to generate the auditory
signal. Dysfunction in any structure of this conduction pathway
may lead to SNHL. Thus, the cochlea and cochlear nerve should
be contoured and protected individually.The largest controversy of parotid gland contouring lies in the
overlap between the parotid gland and CTV. The parotid gland
receives a dose inﬂuenced by the size of the target volume and
prescribed dose. Radiation-induced xerostomia in NPC patients
396 Suggested contouring of the OARs in NPCcan recover years after radiotherapy [35]. Contouring the whole
salivary gland minus the GTV may be more suitable for getting
the better dosimetric parameters that correspond with the change
of salivary function after radiotherapy.
Our recommendation to delineate the true spinal cord is in con-
trast to Kong et al. [15] for the following reasons: The transverse
diameter of the cervical spinal cord is greater than the thoracic
spinal cord, and is easier to visualize. In addition, a PRV was gener-
ated to ensure that the dose not to exceed the tolerance of spinal
cord.
Baxi et al. brieﬂy introduced OARs contouring in nasopharyn-
geal IMRT [11]. We contoured other organs such as the brainstem,
optic nerve et al. according to their 3D anatomical boundaries. The
whole organs should be outlined, including those in CTV, but not
GTV. According to ICRU report 50, the OARs are deﬁned as critical
normal structures. Thus, those overlapping with the GTV, which is
considered as part of the tumor, should not be included. On the
other hand, OARs within the CTV, lacking of evidence of tumor
involvement, should be included. Furthermore, such OARs contour-
ing has also been performed in patients with lung cancer and hepa-
tocellular carcinoma undergoing radiotherapy [15,36]. In this
study, we used the temporal lobe as an example to show how
to deﬁne a reasonable contouring method. Similar steps could be
taken for other organs.
The present atlas is mainly based on CT and refers to MRI. It is
well recognized that MRI has a better resolution for soft tissue, and
is usually used to diagnose the soft tissue disease [37,38]. Thus,
glands, muscles and other soft tissues should be contoured by
referring to MRI. On the other hand, CT can more reliably indicate
bone boundaries and joint structures [39]. Thus, the TMJ, middle/
inner ear and mandible, which are mainly deﬁned by bone limit,
could be contoured based on CT alone.
Conclusions
Different OARs contouring methods result in different dosimet-
ric parameters. A contouring guideline is necessary to facilitate the
generation of uniform and comparable dosimetric parameters. The
present atlas, based on anatomic deﬁnitions and the pathogenesis
of radiation-induced injury, may help reach a consensus on
subjective interpretation of the OARs delineation to reduce inter-
institutional differences in NPC patients.
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